List of works - Amany Zekry

A Tale of Two Fibers: A Liver Twist!

A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.

scientific article

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

scientific article published in August 2008

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

scientific article published in January 2004

Adherence to Hepatitis B Antiviral Therapy: A Qualitative Study

scientific article published on May 2017

Barriers faced by migrants in accessing healthcare for viral hepatitis infection ⬇️

scientific article published on May 1, 2012

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

scientific article published on 11 April 2019

Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders

scientific article published on 14 February 2014

Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection

scientific article published on 01 April 2019

Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes.

scientific article published on June 2009

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

scientific article

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

scientific article published on 28 October 2014

Community screening identifies undiagnosed chronic liver disease in high‐risk populations

Cytokines and liver injury in chronic HCV genotype 4 infection.

scientific article published on March 2009

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

scientific article published on 16 October 2017

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

scientific article published on 20 November 2017

Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

scientific article

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

scientific article

Factors associated with HBV virological breakthrough.

scientific article published on 15 September 2016

Factors associated with medication adherence in patients living with cirrhosis.

scientific article

Factors associated with non-adherence to HBV antiviral therapy.

scientific article published on 22 January 2017

Factors influencing the participation of gastroenterologists and hepatologists in clinical research

scientific article

Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care

General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.

scientific article published in January 2018

General practitioners' knowledge and management of viral hepatitis in the migrant population ⬇️

scientific article published on May 1, 2012

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.

scientific article published in May 2015

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up

Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.

scientific article published on 25 August 2016

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

scientific article published on May 2014

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation ⬇️

scientific article published on November 1, 2003

Insulin resistance and steatosis in hepatitis C virus infection.

scientific article

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.

scientific article published on 24 March 2008

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

scientific article published on March 2002

Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?

scientific article published in January 2007

Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?

scientific article published in December 2004

Knowledge of Treatment and Disease Questionnaire

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

scientific article published on 11 March 2015

MEDICAL COMPLICATIONS OF HOMELESSNESS: A NEGLECTED SIDE OF MEN'S HEALTH

article

Mechanisms of HCV reinfection and allograft damage after liver transplantation

scientific article published on March 2004

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

scholarly article

New Drugs for the Management of Hepatitis C

Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management

scientific article published on 24 November 2019

Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion.

scientific article published in April 2000

Pathogenesis of hepatitis C virus recurrence in the liver allograft

scientific article

Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression

scientific article

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

scientific article published on 19 April 2017

Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination

scientific article published on 09 February 2022

Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver

scientific article published on 01 January 2014

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.

scientific article

Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.

scientific article published on March 2008

Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

scientific article

Standard Therapy for Genotypes 2/3

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

scientific article

Strategies to manage hepatitis C virus (HCV) disease burden.

scientific article published on May 2014

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

scientific article published on 15 March 2009

The long and the short of interferon-gamma–inducible protein 10 in hepatitis C virus infection ⬇️

scientific article published on November 1, 2011

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

scientific article published on May 2014

Tinkering and tailoring with HCV therapy: can we get away with less?

scientific article published on 01 December 2004

Treatment of acute hepatitis C infection: more pieces of the puzzle?

scientific article published on 01 March 2005

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

scientific article

Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.

scientific article

List of works by Amany Zekry

A Tale of Two Fibers: A Liver Twist!

A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

Adherence to Hepatitis B Antiviral Therapy: A Qualitative Study

Barriers faced by migrants in accessing healthcare for viral hepatitis infection ⬇️

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders

Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection

Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes.

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

Community screening identifies undiagnosed chronic liver disease in high‐risk populations

Cytokines and liver injury in chronic HCV genotype 4 infection.

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Factors associated with HBV virological breakthrough.

Factors associated with medication adherence in patients living with cirrhosis.

Factors associated with non-adherence to HBV antiviral therapy.

Factors influencing the participation of gastroenterologists and hepatologists in clinical research

Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care

General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.

General practitioners' knowledge and management of viral hepatitis in the migrant population ⬇️

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up

Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation ⬇️

Insulin resistance and steatosis in hepatitis C virus infection.

Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

Is re-treatment with peginterferon alpha-2a and ribavirin effective in patients with relapsed chronic hepatitis C?

Is the current standard therapy for hepatitis C of peginterferon and ribavirin an option for patients coinfected with HIV?

Knowledge of Treatment and Disease Questionnaire

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

MEDICAL COMPLICATIONS OF HOMELESSNESS: A NEGLECTED SIDE OF MEN'S HEALTH

Mechanisms of HCV reinfection and allograft damage after liver transplantation

Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

New Drugs for the Management of Hepatitis C

Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management

Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion.

Pathogenesis of hepatitis C virus recurrence in the liver allograft

Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination

Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver

Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.

Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C.

Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

Standard Therapy for Genotypes 2/3

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

Strategies to manage hepatitis C virus (HCV) disease burden.

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

The long and the short of interferon-gamma–inducible protein 10 in hepatitis C virus infection ⬇️

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Tinkering and tailoring with HCV therapy: can we get away with less?

Treatment of acute hepatitis C infection: more pieces of the puzzle?

Treatment responses in Asians and Caucasians with chronic hepatitis C infection

Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.

Virtual clinic for positive faecal occult blood tests enhances early access to bowel cancer screening and is well received by patients